AZ shares buoyed by Seroquel patent victory 03-Jul-2008 The US District Court for New Jersey has granted AstraZeneca a summary judgement in its favour Read more...

Call for rigorous diabetes drug tests 03-Jul-2008 A panel of experts has recommended to the US Food and Drug Administration that drugs to control Type II diabetes be subjected to more intensive cardiovascular trials Read more...

Last chance to book table for Communiqué 03-Jul-2008 Booking for the Communiqué awards closes on Monday July 7, 2008 Read more...

Stronger voice for the public on primary care 03-Jul-2008 The Department of Health has published a new strategy that will give patients and the public a stronger voice Read more...

ABPI says children should be protected against hepatitis 02-Jul-2008 The Association of the British Pharmaceutical Industry has published a new report which says that children should be vaccinated against hepatitis to prevent the spread of drug-resistant strains of the disease Read more...

GSK signs product deal with Aspen 02-Jul-2008 GlaxoSmithKline has announced that it is selling four products – Eltroxin, Lanoxin, Imuran and Zyloric – to a subsidiary of South African-based pharmaceuticals group, Aspen Global, for a cash consideration of £170m Read more...

GSK to appeal Alabama Medicaid judgement 02-Jul-2008 GlaxoSmithKline has said it will appeal a court verdict against it regarding the way it reported prices for drugs reimbursed by Medicaid in the State of Alabama Read more...

Football legend backs cancer campaign 01-Jul-2008 World Cup hero Sir Geoff Hurst has helped launch a new campaign appealing to all men with prostate cancer to get access to the best care Read more...

Teva gains FDA approval for generic Risperdal 01-Jul-2008 The US FDA has granted final approval for Israeli drug company, Teva, to market its generic version of Risperdal, an antipsychotic agent manufactured by Janssen Read more...

US approval for Cervarix delayed 01-Jul-2008 GSK has published an update regarding its application to the FDA for US approval of its cervical cancer drug, Cervarix Read more...

Department of Health announces draft NHS constitution 30-Jun-2008 The Department of Health has unveiled a draft constitution, the first of its kind in the world, that ‘enshrines’ the principles and values of the NHS, an institution which it refers to as being too important to be left to chance Read more...

Less pain from needles for children 30-Jun-2008 Zingo, a new drug that reduces pain caused by intravenous lines and blood draws in children aged three to 18 has been launched by Californian biopharmaceutical company, Anesiva Read more...

New EFPIA code comes into effect 30-Jun-2008 A new European Federation of Pharmaceutical Industries and Associations’ Code of Practice which calls for greater transparency in the relationships between drug manufactures and patient organisations comes into effect on July 1, 2008 Read more...

CHMP recommends approval of Abstral 27-Jun-2008 The CHMP has recommended Prostrakan’s cancer pain drug, Abstral, for approval by the EMEA Read more...

GP federations for better care 27-Jun-2008 The RCGP is calling for the use of federations in the drive to raise the standard of patient care and has said that the politicians and doctors should be less concerned with investing in new buildings and NHS real estate Read more...

New drug matches chemo performance 27-Jun-2008 Swiss pharmaceutical company, Roche, has revealed that new data will be presented at the WCGI showing that patients taking capecitabine can live up to five years after bowel cancer surgery   Read more...